Alkermes plc. (ALKS) Financial Statements (2025 and earlier)
Company Profile
| Business Address |
CONNAUGHT HOUSE DUBLIN 4, 00000 |
| State of Incorp. | |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in millions)
| 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 773 | 608 | 536 | 635 | 535 | 539 | |||
| Cash and cash equivalent | 457 | 292 | 338 | 273 | 204 | 267 | |||
| Short-term investments | 316 | 316 | 199 | 362 | 331 | 273 | |||
| Receivables | 332 | 288 | 313 | 275 | 257 | 292 | |||
| Inventory, net of allowances, customer advances and progress billings | 186 | 181 | 150 | 126 | 102 | 90 | |||
| Inventory | 186 | 181 | 150 | 126 | 102 | 90 | |||
| Contract with customer, asset, after allowance for credit loss | 1 | 9 | 13 | 14 | 8 | 8 | |||
| Asset, held-for-sale, not part of disposal group | 94 | ||||||||
| Business combination, contingent consideration, asset | 6 | 8 | |||||||
| Other undisclosed current assets | 98 | 44 | 43 | 53 | 60 | 53 | |||
| Total current assets: | 1,486 | 1,130 | 1,062 | 1,111 | 962 | 983 | |||
| Noncurrent Assets | |||||||||
| Operating lease, right-of-use asset | 91 | 116 | 116 | 132 | 12 | ✕ | |||
| Property, plant and equipment | 227 | 325 | 341 | 350 | 362 | 310 | |||
| Long-term investments and receivables | 40 | 132 | 229 | 25 | 79 | 81 | |||
| Long-term investments | 40 | 132 | 229 | 25 | 79 | 81 | |||
| Intangible assets, net (including goodwill) | 85 | 131 | 167 | 204 | 244 | 284 | |||
| Goodwill | 83 | 93 | 93 | 93 | 93 | 93 | |||
| Intangible assets, net (excluding goodwill) | 2 | 38 | 74 | 111 | 151 | 191 | |||
| Deferred income tax assets | 196 | 116 | 82 | 86 | ✕ | ||||
| Business combination, contingent consideration, asset | 17 | 25 | 32 | 65 | |||||
| Other noncurrent assets | 12 | 15 | 11 | 17 | 17 | 16 | |||
| Other undisclosed noncurrent assets | 97 | 86 | |||||||
| Total noncurrent assets: | 651 | 834 | 962 | 839 | 843 | 842 | |||
| TOTAL ASSETS: | 2,136 | 1,964 | 2,024 | 1,950 | 1,805 | 1,825 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities, including: | 241 | 220 | 446 | 412 | 373 | 334 | |||
| Employee-related liabilities | ✕ | ✕ | ✕ | 77 | 71 | ||||
| Accounts payable | 66 | 33 | 56 | 46 | 54 | 40 | |||
| Accrued liabilities | 175 | 187 | 76 | 76 | 93 | 73 | |||
| Other undisclosed accounts payable and accrued liabilities | 237 | 219 | 226 | 221 | |||||
| Deferred revenue | 3 | 7 | 6 | 8 | 7 | ✕ | |||
| Debt | 3 | 3 | 3 | 3 | 11 | 3 | |||
| Disposal group, including discontinued operation | 5 | ||||||||
| Contract with customer, liability | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | 3 | ||
| Other undisclosed current liabilities | 269 | 268 | 16 | 16 | |||||
| Total current liabilities: | 520 | 498 | 471 | 438 | 391 | 340 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 288 | 290 | 397 | 392 | 280 | 276 | |||
| Long-term debt, excluding current maturities | 288 | 290 | 293 | 272 | 274 | 276 | |||
| Liabilities, other than long-term debt | 126 | 132 | 44 | 53 | 49 | 37 | |||
| Deferred revenue | 11 | 16 | 22 | ✕ | |||||
| Contract with customer, liability | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | 10 | ||
| Other liabilities | 50 | 42 | 32 | 37 | 27 | 28 | |||
| Operating lease, liability | 76 | 90 | 104 | 119 | 5 | ✕ | |||
| Total noncurrent liabilities: | 413 | 422 | 441 | 444 | 329 | 314 | |||
| Total liabilities: | 934 | 920 | 912 | 883 | 720 | 654 | |||
| Equity | |||||||||
| Equity, attributable to parent | 1,203 | 1,044 | 1,113 | 1,067 | 1,085 | 1,171 | |||
| Common stock | 2 | 2 | 2 | 2 | 2 | 2 | |||
| Treasury stock, value | (189) | (161) | (143) | (126) | (118) | (109) | |||
| Additional paid in capital | 2,737 | 2,913 | 2,798 | 2,686 | 2,586 | 2,467 | |||
| Accumulated other comprehensive loss | (3) | (11) | (4) | (1) | (2) | (3) | |||
| Accumulated deficit | (1,344) | (1,699) | (1,541) | (1,493) | (1,382) | (1,185) | |||
| Total equity: | 1,203 | 1,044 | 1,113 | 1,067 | 1,085 | 1,171 | |||
| TOTAL LIABILITIES AND EQUITY: | 2,136 | 1,964 | 2,024 | 1,950 | 1,805 | 1,825 | |||
Income Statement (P&L) ($ in millions)
| 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 1,663 | 1,112 | 1,174 | 1,039 | 1,171 | 1,094 | ||
| Cost of revenue (Cost of Product and Service Sold) | (253) | (218) | (197) | (178) | (180) | (176) | ||
| Gross profit: | 1,410 | 894 | 976 | 860 | 991 | 918 | ||
| Operating expenses | (996) | (1,036) | (1,006) | (973) | (1,166) | (1,017) | ||
| Operating income (loss): | 414 | (142) | (29) | (112) | (175) | (99) | ||
| Nonoperating income (expense) | 7 | (25) | (10) | 16 | (22) | (28) | ||
| Investment income, nonoperating | 31 | 8 | 2 | 7 | 14 | 9 | ||
| Other nonoperating income (expense) | (0) | 2 | 0 | 14 | 1 | (2) | ||
| Interest and debt expense | (23) | (13) | (0) | (9) | (14) | (2) | ||
| Other undisclosed income from continuing operations before equity method investments, income taxes | 9 | 14 | 2 | |||||
| Income (loss) from continuing operations before equity method investments, income taxes: | 398 | (180) | (39) | (97) | (197) | (127) | ||
| Other undisclosed income from continuing operations before income taxes | 23 | 13 | 0 | |||||
| Income (loss) from continuing operations before income taxes: | 422 | (167) | (39) | (97) | (197) | (127) | ||
| Income tax expense (benefit) | 98 | 9 | (9) | (14) | 0 | (12) | ||
| Income (loss) from continuing operations: | 519 | (158) | (48) | (111) | (197) | (139) | ||
| Loss before gain (loss) on sale of properties: | ✕ | ✕ | ✕ | (48) | (111) | (197) | (139) | |
| Loss from discontinued operations | (165) | |||||||
| Other undisclosed net income | 1 | |||||||
| Net income (loss) available to common stockholders, diluted: | 356 | (158) | (48) | (111) | (197) | (139) | ||
Comprehensive Income ($ in millions)
| 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | ||
|---|---|---|---|---|---|---|---|---|
| Net income (loss): | 356 | (158) | (48) | (111) | (197) | (139) | ||
| Comprehensive income (loss): | 356 | (158) | (48) | (111) | (197) | (139) | ||
| Other undisclosed comprehensive income (loss), net of tax, attributable to parent | 8 | (7) | (2) | 0 | 1 | 1 | ||
| Comprehensive income (loss), net of tax, attributable to parent: | 364 | (165) | (51) | (110) | (195) | (139) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.